Last reviewed · How we verify
MM09 Mannosylated 10.000 subcutaneous
At a glance
| Generic name | MM09 Mannosylated 10.000 subcutaneous |
|---|
| Sponsor | Inmunotek S.L. |
|---|
| Modality | Biologic |
|---|
| Phase | Phase 2 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.